These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 2122427)
21. Confirmation for combination AIDS therapy. Science; 1995 Oct; 270(5233):33. PubMed ID: 7569948 [No Abstract] [Full Text] [Related]
22. [Antiretroviral treatment. Present and future of the combinations]. Gatell-Artigas JM Rev Neurol; 1996 Dec; 24(136):1627-31. PubMed ID: 9064189 [TBL] [Abstract][Full Text] [Related]
23. Research study of combination AIDS therapies underway. AIDS Patient Care STDS; 1996 Apr; 10(2):132. PubMed ID: 11361697 [No Abstract] [Full Text] [Related]
24. ACTG 175 and Delta. Torres G GMHC Treat Issues; 1995 Oct; 9(10):2-3. PubMed ID: 11362915 [TBL] [Abstract][Full Text] [Related]
25. New trials reach same conclusion: two drugs are better than AZT alone. AIDS Alert; 1995 Nov; 10(11):133-6. PubMed ID: 11362921 [TBL] [Abstract][Full Text] [Related]
27. Can the conundrums of ACTG 175 be solved? An interview with Martin S. Hirsch, MD. Hirsch MS J Int Assoc Physicians AIDS Care; 1995 Oct; 1(9):29-30. PubMed ID: 11362965 [TBL] [Abstract][Full Text] [Related]
29. [Anti-HIV-therapy. Monotherapy with drugs delaying the course of the disease has limited effect]. Julander I; Britton S Lakartidningen; 1994 Jul; 91(30-31):2759, 2762-3. PubMed ID: 7520104 [No Abstract] [Full Text] [Related]
30. Tenofovir-related Fanconi syndrome with nephrogenic diabetes insipidus in a patient with acquired immunodeficiency syndrome: the role of lopinavir-ritonavir-didanosine. Rollot F; Nazal EM; Chauvelot-Moachon L; Kélaïdi C; Daniel N; Saba M; Abad S; Blanche P Clin Infect Dis; 2003 Dec; 37(12):e174-6. PubMed ID: 14689363 [TBL] [Abstract][Full Text] [Related]
31. [Nevirapine: a new principle of action against HIV]. Dtsch Med Wochenschr; 1996 Dec; 121(49):A48-9. PubMed ID: 8998915 [No Abstract] [Full Text] [Related]
32. AIDS: The good news and the bad. Minn Med; 1989 Sep; 72(9):533-4. PubMed ID: 2571920 [No Abstract] [Full Text] [Related]
33. FDA makes AIDS drug available before tests are complete. RN; 1991 Dec; 54(12):112. PubMed ID: 1749903 [No Abstract] [Full Text] [Related]
34. A semiparametric Bayesian approach to the random effects model. Kleinman KP; Ibrahim JG Biometrics; 1998 Sep; 54(3):921-38. PubMed ID: 9750242 [TBL] [Abstract][Full Text] [Related]
35. Dose of doubt. Day M Nurs Times; 1994 Jul 13-19; 90(28):20. PubMed ID: 8065956 [No Abstract] [Full Text] [Related]
36. In vivo inhibition of syncytium-inducing variants of HIV in patients treated with didanosine. Delforge ML; Liesnard C; Debaisieux L; Tchetcheroff M; Farber CM; Van Vooren JP AIDS; 1995 Jan; 9(1):89-90. PubMed ID: 7893446 [No Abstract] [Full Text] [Related]
37. T69D/N pol mutation, human immunodeficiency virus type 1 RNA levels, and syncytium-inducing phenotype are associated with CD4 cell depletion during didanosine therapy. Naugler WE; Yong FH; Carey VJ; Dragavon JA; Coombs RW; Frenkel LM J Infect Dis; 2002 Feb; 185(4):448-55. PubMed ID: 11865396 [TBL] [Abstract][Full Text] [Related]
38. Government ddI trials on trial. Palca J Science; 1989 Dec; 246(4935):1244. PubMed ID: 2511632 [No Abstract] [Full Text] [Related]
39. Update on reverse transcriptase inhibitors in HIV disease. Carr A; Loewenthal M; Cooper DA Isr J Med Sci; 1993 Oct; 29(10 Suppl):26-30. PubMed ID: 7503966 [No Abstract] [Full Text] [Related]